| Literature DB >> 27233360 |
Moniba Sajid1, Muhammad Rashid Khan1, Naseer Ali Shah2, Shafi Ullah1, Tahira Younis1, Muhammad Majid1, Bushra Ahmad3, Dereje Nigussie4.
Abstract
BACKGROUND: Artemisia scoparia is traditionally used in the local system of medicine in kidney disorders. This study aimed at scrutinizing the nephroprotective prospective of A. scoparia methanol extract against carbon tetrachloride (CCl4) provoked DNA damages and oxidative stress in kidneys of rat.Entities:
Keywords: Antioxidant; Artemisia scoparia; Comet assay; DNA damages; Kidneys; Lipid peroxidation
Mesh:
Substances:
Year: 2016 PMID: 27233360 PMCID: PMC4884399 DOI: 10.1186/s12906-016-1137-6
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Protective effects of ASM on comet parameters in renal cells
| Group | Comet length (μm) | Head length (μm) | Tail length (μm) | % DNA in head | % DNA in tail | Tail moment (μm) |
|---|---|---|---|---|---|---|
| Control | 41.48 ± 2.63 | 35.04 ± 1.81 | 6.61 ± 1.03 | 91.33 ± 2.21 | 9.53 ± 1.13 | 0.51 ± 0.031 |
| Olive oil + DMSO | 40.85 ± 2.39 | 34.58 ± 1.78 | 6.36 ± 0.68 | 90.36 ± 2.43 | 10.11 ± 1.04 | 0.61 ± 0.023 |
| CCl4 | 63.16 ± 2.11aab | 23.29 ± 1.50ab | 39.21 ± 2.81ab | 74.81 ± 2.18ab | 25.28 ± 1.40ab | 0.64 ± 0.019 |
| CCl4 + Sily (100) | 41.54 ± 2.56c | 34.94 ± 2.06c | 6.35 ± 0.71c | 90.46 ± 2.52c | 9.70 ± 1.19bc | 0.44 ± 0.021c |
| CCl4 + ASM (150) | 46.76 ± 1.74 | 28.22 ± 2.21 | 18.78 ± 1.62 | 84.53 ± 2.32 | 15.95 ± 1.42 | 0.60 ± 0.025 |
| CCl4 + ASM (300) | 40.80 ± 2.60c | 34.70 ± 2.21c | 7.43 ± 1.24c | 88.03 ± 2.27c | 11.66 ± 1.45c | 0.45 ± 0.018c |
| ASM (300) | 43.20 ± 3.21 | 34.67 ± 2.23c | 9.26 ± 1.57c | 89.98 ± 1.95c | 10.35 ± 1.16c | 0.11 ± 0.024bc |
Values are expressed as mean ± SD (n = 6), Sily. Silymarin; ASM: A. scoparia methanol extract. Means with letter “a” indicate significant difference from control, “b” from vehicle control and “c” from CCl4 treated group according to Kruskal-Wallis test at P < 0.05
Fig. 1Fluorescence photomicrograph of kidney cells and protective outcome of ASM on genotoxicity. a Control group; b Vehicle control, c CCl4(1 ml/kg b.w., i.p., 30 % in olive oil group; d CCl4+ silymarin (100 mg/kg); e CCl4 + ASM (150 mg/kg); f CCl4 + ASM (300 mg/kg); g ASM (300 mg/kg). ASM; A. scoparia methanol extract; H, Comet head; T, Comet tail
Protective outcomes of ASM on serum markers
| Treatment | Urea | Creatinine | Bilirubin | Serum proteins | BUN |
|---|---|---|---|---|---|
| Control | 29.97 ± 2.43 | 0.49 ± 0.025 | 0.39 ± 0.024 | 6.15 ± 0.19 | 13.15 ± 1.49 |
| Olive oil + DMSO | 28.00 ± 2.10 | 0.43 ± 0.018 | 0.42 ± 0.027a | 6.07 ± 0.09 | 12.67 ± 1.61 |
| CCl4 | 72.02 ± 1.96 | 1.52 ± 0.064b | 1.97 ± 0.077ab | 3.82 ± 0.12ab | 30.49 ± 2.28ab |
| CCl4 + Sily (100) | 30.03 ± 1.83 | 0.41 ± 0.034 ac | 0.88 ± 0.030a | 5.74 ± 0.21 | 13.16 ± 1.18c |
| CCl4 + ASM (150) | 23.37 ± 2.05c | 0.61 ± 0.035b | 0.92 ± 0.022a | 5.05 ± 0.18ab | 23.78 ± 1.76b |
| CCl4 + ASM (300) | 26.32 ± 2.06c | 0.56 ± 0.024 | 0.83 ± 0.023 | 5.66 ± 0.24 | 19.95 ± 1.97 |
| ASM (300) | 28.79 ± 1.54 | 0.43 ± 0.035c | 0.41 ± 0.023c | 5.95 ± 0.23c | 12.89 ± 1.26c |
Mean ± SD (n = 6), Sily: Silymirin; ASM: A. scoparia methanol extract. Means with letter “a” indicate significant difference from control, “b” from vehicle control and “c” from CCl4 treated group according to Kruskal-Wallis test at P < 0.05
Protective effects of ASM on renal antioxidant enzymes
| Treatment | CAT | POD | SOD | GST | γ-GT |
|---|---|---|---|---|---|
| Control | 5.48 ± 0.16 | 7.42 ± 0.57 | 3.24 ± 0.27 | 21.55 ± 1.48 | 81.47 ± 2.97 |
| Olive oil + DMSO | 4.57 ± 0.50 | 6.85 ± 0.36 | 2.76 ± 0.25 | 22.48 ± 1.68 | 83.10 ± 2.53 |
| CCl4 | 1.20 ± 0.13a | 0.93 ± 0.12ab | 0.84 ± 0.13ab | 08.95 ± 0.91ab | 40.88 ± 2.78ab |
| CCl4 + Sily (100) | 4.18 ± 0.23 | 6.71 ± 0.42 | 2.51 ± 0.17 | 21.11 ± 1.42c | 80.11 ± 2.68c |
| CCl4 + ASM (150) | 2.43 ± 0.20a | 4.74 ± 0.30 | 1.89 ± 0.17a | 16.58 ± 1.14b | 61.11 ± 2.78b |
| CCl4 + ASM (300) | 4.41 ± 0.31 | 6.81 ± 0.48 | 2.60 ± 0.21 | 20.50 ± 1.91 | 69.06 ± 3.96 |
| ASM (300) | 5.16 ± 0.32c | 6.93 ± 0.46c | 3.15 ± 0.27c | 20.98 ± 1.90c | 83.00 ± 2.84c |
Mean ± SD (n = 6), Sily: Silymirin; ASM: A. scoparia methanol extract. Means with letter “a” indicate significant difference from control, “b” from vehicle control and “c” from CCl4 treated group according to Kruskal-Wallis test at P < 0.05
Protective outcome of ASME on biochemical parameters in rat kidney
| Treatment | Proteins (μg/mg tissue) | GSH (μM/g tissue) | TBARS (nM/min/mgprotein) | H2O2
| Nitrite |
|---|---|---|---|---|---|
| Control | 2.41 ± 0.16 | 19.30 ± 1.35 | 22.35 ± 2.22 | 0.26 ± 0.02 | 51.97 ± 3.11 |
| Olive oil + DMSO | 2.55 ± 0.09 | 18.51 ± 2.03 | 22.08 ± 1.85 | 0.24 ± 0.02 | 50.41 ± 3.04 |
| CCl4 | 1.06 ± 0.10ab | 3.75 ± 0.25ab | 44.52 ± 3.58ab | 0.62 ± 0.02ab | 91.74 ± 3.84ab |
| CCl4 + Sily (100) | 2.43 ± 0.14c | 18.36 ± 1.64c | 23.55 ± 2.16 | 0.26 ± 0.02bc | 52.61 ± 3.16 |
| CCl4 + ASM (150) | 1.68 ± 0.18b | 09.45 ± 0.94a | 25.45 ± 1.43 | 0.42 ± 0.02bc | 54.12 ± 3.05 |
| CCl4 + ASM (300) | 2.14 ± 0.12 | 14.25 ± 1.25 | 22.96 ± 1.80c | 0.31 ± 0.04 | 52.85 ± 3.03 |
| ASM (300) | 2.30 ± 0.17 | 17.83 ± 1.19c | 22.33 ± 1.83c | 0.30 ± 0.02 | 51.49 ± 2.74c |
Mean ± SD (n = 6), Sily: Silymirin; ASM: A. scoparia methanol extract. Means with letter “a” indicate significant difference from control, “b” from vehicle control and “c” from CCl4 treated group according to Kruskal-Wallis test at P < 0.05
Fig. 2Protective outcome of ASM on histology of renal tissues (40X magnification). a Control group; b Vehicle control, c, d CCl4 (1 ml/kg b.w., i.p., 30 % in olive oil group; e CCl4 + silymarin (100 mg/kg); f CCl4 + ASM (150 mg/kg); g CCl4 + ASM (300 mg/kg); h ASM (300 mg/kg). G, glomerulus; BC, Bowman’s capsule; O, interstitial edema; H, glomerular hypocellularity; N, necrosis of epithelium; PC, proximal convoluted tubule; BB, brush border; DC, distal convoluted tubule; DCT, dilated proximal convoluted tubule; RT, renal tubule; LBB loss of brush border; DCG, degenerative changes in glomerulus; RBC, regenerating Bowman’s capsule; NS, normal space between Bowman’s capsule and glomerulus; DS, decreased space between Bowman’s capsule and glomerulus